Sección para completar los datos relacionados con las publicaciones que sirven de base al protocolo. Refiera hasta un máximo de 10 referencias.
Referencias:
1. Bénichou C. Criteria of drug-induced liver disorders Report of an International Consensus Meeting. J Hepatol. 1990;11:272–6.
2. Sistanizad M, Peterson GM. Drug-induced liver injury in the Australian setting. J Clin Pharm Ther. 2013;38(2):115–20.
3. Reuben A. Hy’s Law. Hepatology. 2004;39(2):574–8.
4. Bjornsson E. Drug-induced liver injury: Hy’s rule revisited. Clin Pharmacol Ther. 2006;79(6):521–8.
5. Tejada F. Hepatotoxicidad por Fármacos. Rev clínica Med Fam. 2010;3(3):177–91.
6. Ibáñez L, Pérez E, Vidal X, Laporte JR. Prospective surveillance of acute serious liver disease unrelated to infectious, obstructive, or metabolic diseases: Epidemiological and clinical features, and exposure to drugs. J Hepatol. 2002;37(5):592–600.
7. Sgro C, Clinard F, Ouazir K, Chanay H, Allard C, Guilleminet C, et al. Incidence of drug-induced hepatic injuries: A French population-based study. Hepatology. 2002;36(2):451–5.
8. Fisher K, Vuppalanchi R, Saxena R. Drug-Induced Liver Injury. Arch Pathol Lab Med. 2015;139:876–87
Resultados:
Cano A, Cifuentes L, Amariles P. Structured Literature Review of Hepatic Toxicity Caused by Medicines. Rev Colomb Gastroenterol 2017; 32(4): 337–48
Versión para impresión